China: Novogene Technology closes $75m Series B from CMB International, SDIC Unit

China: Novogene Technology closes $75m Series B from CMB International, SDIC Unit

Array of suspended genetic helixes

Beijing-based Novogene Technology Co., Ltd., a commercial provider of genomic services and solutions with next-generation sequencing (NGS) and bioinformatics expertise, has completed a $75 Million (RMB515 Million) Series B round financing led by China Merchants Bank Co., Ltd.’s CMB International Capital Management (Shenzhen) Co., Ltd. (CMB International).

Other investors participating in the round are SDIC Innovation Investment Management Co., Ltd. (SDIC Innovation) and Shanghai Sigma Square Investment Center LP (Sigma Square Capital).

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter